The antiparkinsonian agent budipine is an N-methyl-D-aspartate antagonist

References

Page 1

	Year	Citations
Quinoxalinediones: Potent Competitive Non-NMDA Glutamate Receptor Antagonists Tage Honoré, S.N. Davies, Jørgen Drejer, Science Synaptic TransmissionNeurotransmitterPharmacotherapyNeurotransmissionGlutamate Receptors	1988	1.2K
Protection of substantia nigra from MPP+ neurotoxicity by N-methyl-D-aspartate antagonists Lechosław Turski, Karin Bressler, Klaus Jürgen Rettig, Nature Substantia NigraMedicinePsychotropic MedicationNeuropharmacologyPharmacotherapy	1991	549
The NMDA antagonist MK-801 causes marked locomotor stimulation in monoamine-depleted mice Maria Carlsson, Arvid Carlsson Journal of Neural Transmission Psychoactive DrugPsychiatryNeurophysiologyMedicineNmda Antagonist Mk-801	1989	426
MK-801, a proposed noncompetitive antagonist of excitatory amino acid neurotransmission, produces phencyclidine-like behavioral effects in pigeons, rats and rhesus monkeys. Wouter Koek, J H Woods, Gail Winger Journal of Pharmacology and Experimental Therapeutics	1988	306
NMDA antagonists potentiate antiparkinsonian actions of <scp>L</scp>‐dopa in monoamine‐depleted rats Thomas Klockgether, Lechosław Turski Annals of Neurology MedicineSynaptic TransmissionPsychopharmacologyNeuropharmacologySubthalamic Nucleus	1990	285
Anticataleptic effects of the N-methyl-D-aspartate antagonist MK-801 in rats Werner Schmidt, Michael Bubser Pharmacology Biochemistry and Behavior MedicineAnticataleptic EffectsNeuropharmacologyExperimental PharmacologyPharmacotherapy	1989	168
Synergism of the AMPA-antagonist NBQX and the NMDA-antagonist CPP with L-Dopa in models of Parkinson's disease P.-A. Löschmann, Klaus W. Lange, Margrit Kunow, Journal of Neural Transmission - Parkinsons Disease and Dementia Section NeurophysiologyAmpa-antagonist NbqxMedicineNeurotransmitterNeuropharmacology	1991	134
Modulation of the seizure threshold for excitatory amino acids in mice by antiepileptic drugs and chemoconvulsants. K G Steppuhn, L. Turski Journal of Pharmacology and Experimental Therapeutics	1993	66
Differential effects of the excitatory amino acid antagonists, 6-cyano-7-nitroquinoxaline-2,3-dione (CNQX) and 3-((±)-2-carboxypiperazin-4-yl)-propyl-1-phosphonic acid (CPP), on spinal reflex activity in mice Lechosław Turski, Karin Bressler, Thomas Klockgether, Neuroscience Letters Synaptic TransmissionAnesthetic MechanismPharmacotherapyExperimental PharmacologyMolecular Pharmacology	1990	42
Adjuvant treatment of Parkinson's disease with budipine: a double-blind trial versus placebo K. A. Jellinger, H Bliesath Journal of Neurology MedicineNeuropharmacologyAdjuvant TreatmentPharmacotherapyNeurology	1987	32

Page 1